These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20395859)

  • 1. Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.
    Saxena A; Chua TC; Bester L; Kokandi A; Morris DL
    Ann Surg; 2010 May; 251(5):910-6. PubMed ID: 20395859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
    Gonsalves CF; Eschelman DJ; Adamo RD; Anne PR; Orloff MM; Terai M; Hage AN; Yi M; Chervoneva I; Sato T
    Radiology; 2019 Oct; 293(1):223-231. PubMed ID: 31453767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
    Ammann M; Gudmundsdottir H; Hackl H; Antwi SKA; Santol J; Habermann EB; Thiels CA; Warner SG; Truty MJ; Kendrick ML; Smoot RL; Nagorney DM; Cleary SP; Halfdanarson TR; Starlinger PP
    Ann Surg Oncol; 2024 Aug; 31(8):4931-4941. PubMed ID: 38717544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer.
    Puleo L; Agate L; Bargellini I; Boni G; Piaggi P; Traino C; Depalo T; Lorenzoni G; Bianchi F; Volterrani D; Brogioni S; Bottici V; Brunetto MR; Coco B; Molinaro E; Elisei R
    Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36126186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response.
    Rosenbaum CE; van den Hoven AF; Braat MN; Koopman M; Lam MG; Zonnenberg BA; Verkooijen HM; van den Bosch MA
    EJNMMI Res; 2016 Dec; 6(1):92. PubMed ID: 28004357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.
    Peker A; Çiçek O; Soydal Ç; Küçük NÖ; Bilgiç S
    Diagn Interv Radiol; 2015; 21(1):54-9. PubMed ID: 25430526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies for neuroendocrine liver metastases.
    Frilling A; Clift AK
    Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Radioembolization in Metastatic Neuroendocrine Tumors.
    Lewandowski RJ; Toskich BB; Brown DB; El-Haddad G; Padia SA
    Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1590-1598. PubMed ID: 35918431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
    Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
    BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures.
    Cazzato RL; Hubelé F; De Marini P; Ouvrard E; Salvadori J; Addeo P; Garnon J; Kurtz JE; Greget M; Mertz L; Goichot B; Gangi A; Imperiale A
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization of Secondary Hepatic Malignancies.
    Manchec B; Kokabi N; Narayanan G; Niekamp A; Peña C; Powell A; Schiro B; Gandhi R
    Semin Intervent Radiol; 2021 Oct; 38(4):445-452. PubMed ID: 34629712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resection.
    Bösch F; Ilhan H; Pfahler V; Thomas M; Knösel T; Eibl V; Pratschke S; Bartenstein P; Seidensticker M; Auernhammer CJ; Spitzweg C; Guba MO; Werner J; Angele MK
    Hepatobiliary Surg Nutr; 2020 Jun; 9(3):312-321. PubMed ID: 32509817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors.
    Dermine S; Palmieri LJ; Lavolé J; Barré A; Dohan A; Abou Ali E; Cottereau AS; Gaujoux S; Brezault C; Chaussade S; Coriat R
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31703375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Luo Y; Ameli S; Pandey A; Khoshpouri P; Ghasabeh MA; Pandey P; Li Z; Hu D; Kamel IR
    Eur Radiol; 2019 Nov; 29(11):5804-5812. PubMed ID: 31073860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and toxicity following Yttrium-90 radioembolization for hepatic metastases from neuroendocrine tumors-a single-institution experience.
    Zuckerman DA; Kennard RF; Roy A; Parikh PJ; Weiner AA
    J Gastrointest Oncol; 2019 Feb; 10(1):118-127. PubMed ID: 30788167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.
    Golfieri R
    Hepat Oncol; 2014 Jun; 1(3):265-283. PubMed ID: 30190962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.
    Weiner AA; Gui B; Newman NB; Nosher JL; Yousseff F; Lu SE; Foltz GM; Carpizo D; Lowenthal J; Zuckerman DA; Benson B; Olsen JR; Jabbour SK; Parikh PJ
    J Vasc Interv Radiol; 2018 Aug; 29(8):1094-1100. PubMed ID: 29754852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons.
    Sposito C; Droz Dit Busset M; Citterio D; Bongini M; Mazzaferro V
    Rev Endocr Metab Disord; 2017 Dec; 18(4):473-483. PubMed ID: 29359266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
    Kennedy A; Brown DB; Feilchenfeldt J; Marshall J; Wasan H; Fakih M; Gibbs P; Knuth A; Sangro B; Soulen MC; Pittari G; Sharma RA
    J Gastrointest Oncol; 2017 Dec; 8(6):1079-1099. PubMed ID: 29299370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.